A roadmap for developing and engineering in vitro pulmonary fibrosis models
Biophysics Reviews · 01.06.2023 · 4 (2)
DOI: 10.1063/5.0134177 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biophysics Reviews, online erschienen am 28.04.2023. Verfasst von Mohammadhossein Dabaghi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Firestone Institute for Respiratory Health-Division of Respirology, Department of Medicine, McMaster University, St. Joseph's Healthcare Hamilton, 50…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 293 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canada Research Chairs program.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a severe form of pulmonary fibrosis. IPF is a fatal disease with no cure and is challenging to diagnose. Unfortunately, due to the elusive etiology of IPF and a late diagnosis, there are no cures for IPF. Two FDA-approved drugs for IPF, nintedanib and pirfenidone, slow the progression of the disease, yet fail to cure or reverse it. Furthermore, most animal models have been unable to completely recapitulate the physiology of human IPF, resulting in the failure of many drug candidates in preclinical studies. In the last few decades, the development of new IPF drugs focused on changes at the cellular level, as it was believed that the cells were the main players in IPF development and progression. However, recent studies have shed light on the critical role of the extracellular matrix (ECM) in IPF development, where the ECM communicates with cells and initiates a positive feedback loop to promote fibrotic processes. Stemming from this shift in the understanding of fibrosis, there is a need to develop in vitro model systems that mimic the human lung microenvironment to better understand how biochemical and biomechanical cues drive fibrotic processes in IPF. However, current in vitro cell culture platforms, which may include substrates with different stiffness or natural hydrogels, have shortcomings in recapitulating the complexity of fibrosis. This review aims to draw a roadmap for developing advanced in vitro pulmonary fibrosis models, which can be leveraged to understand better different mechanisms involved in IPF and develop drug candidates with improved efficacy. We begin with a brief overview defining pulmonary fibrosis and highlight the importance of ECM components in the disease progression. We focus on fibroblasts and myofibroblasts in the context of ECM biology and fibrotic processes, as most conventional advanced in vitro models of pulmonary fibrosis use these cell types. We transition to discussing the parameters of the 3D microenvironment that are relevant in pulmonary fibrosis progression. Finally, the review ends by summarizing the state of the art in the field and future directions.
Autor:innen und Institutionen
- Firestone Institute for Respiratory Health-Division of Respirology, Department of Medicine, McMaster University, St. Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada.
- Department of Chemistry and Chemical Biology, McMaster University, Arthur N. Bourns Science Building, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada.
- School of Biomedical Engineering, McMaster University, Engineering Technology Building, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.
ORCID-Profile: Mohammadhossein Dabaghi, Mabel Barreiro Carpio, Jose Manuel Moran-Mirabal, Martin R Kolb, Jeremy A Hirota
Förderung
- Canada Research Chairs program
Zitieren
APA
Dabaghi, M., Carpio, M. B., Saraei, N., Moran-Mirabal, J. M., Kolb, M. R., & Hirota, J. A. (2023). A roadmap for developing and engineering in vitro pulmonary fibrosis models. Biophysics Reviews, 4(2). https://doi.org/10.1063/5.0134177
Vancouver
Dabaghi M, Carpio MB, Saraei N, Moran-Mirabal JM, Kolb MR, Hirota JA. A roadmap for developing and engineering in vitro pulmonary fibrosis models. Biophysics Reviews. 2023;4(2). doi:10.1063/5.0134177
BibTeX
@article{Dabaghi2023,
author = {Dabaghi, Mohammadhossein and Carpio, Mabel Barreiro and Saraei, Neda and Moran-Mirabal, Jose Manuel and Kolb, Martin R and Hirota, Jeremy A},
title = {A roadmap for developing and engineering in vitro pulmonary fibrosis models},
journal = {Biophysics Reviews},
year = {2023},
volume = {4},
number = {2},
doi = {10.1063/5.0134177}
}
EUVIMED